Plexus (NASDAQ:PLXS) Lowered to Strong Sell Rating by Zacks Research

Zacks Research lowered shares of Plexus (NASDAQ:PLXS) from a hold rating to a strong sell rating in a report published on Wednesday,Zacks.com reports. Zacks Research also issued estimates for Plexus’ Q3 2026 earnings at $1.16 EPS, Q4 2026 earnings at $1.45 EPS, FY2026 earnings at $5.86 EPS, Q1 2027 earnings at $1.49 EPS, Q2 2027 earnings at $1.60 EPS, Q3 2027 earnings at $1.48 EPS, Q4 2027 earnings at $1.91 EPS, FY2027 earnings at $6.49 EPS, Q1 2028 earnings at $2.02 EPS, Q2 2028 earnings at $2.04 EPS and FY2028 earnings at $8.17 EPS.

A number of other equities analysts have also commented on the stock. Raymond James Financial reiterated an “outperform” rating and issued a $275.00 price objective on shares of Plexus in a report on Thursday, April 30th. Needham & Company LLC boosted their target price on shares of Plexus from $206.00 to $285.00 and gave the stock a “buy” rating in a research report on Friday, May 1st. Williams Trading set a $195.00 target price on shares of Plexus in a research report on Wednesday, January 28th. Benchmark reissued a “buy” rating and issued a $220.00 target price on shares of Plexus in a research report on Monday, March 16th. Finally, Stifel Nicolaus set a $250.00 target price on shares of Plexus and gave the stock a “buy” rating in a research report on Monday, April 20th. Five research analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, Plexus currently has a consensus rating of “Moderate Buy” and an average target price of $229.17.

Plexus Stock Down 0.8%

Shares of PLXS opened at $256.38 on Wednesday. The firm has a market cap of $6.86 billion, a PE ratio of 37.48 and a beta of 0.88. The company’s fifty day moving average is $228.85 and its two-hundred day moving average is $189.62. Plexus has a fifty-two week low of $115.35 and a fifty-two week high of $275.83. The company has a quick ratio of 0.74, a current ratio of 1.54 and a debt-to-equity ratio of 0.06.

Plexus (NASDAQ:PLXS) last posted its earnings results on Wednesday, April 29th. The technology company reported $2.05 earnings per share for the quarter, beating the consensus estimate of $1.87 by $0.18. The business had revenue of $1.16 billion for the quarter, compared to analyst estimates of $1.13 billion. Plexus had a net margin of 4.35% and a return on equity of 12.84%. The business’s quarterly revenue was up 18.7% on a year-over-year basis. During the same quarter in the previous year, the business posted $1.66 EPS. Plexus has set its Q3 2026 guidance at 2.020-2.180 EPS. Analysts forecast that Plexus will post 5.97 earnings per share for the current year.

Insider Activity at Plexus

In related news, Director Karen Marie Rapp sold 500 shares of the stock in a transaction that occurred on Friday, February 27th. The shares were sold at an average price of $195.59, for a total transaction of $97,795.00. Following the completion of the sale, the director directly owned 8,535 shares of the company’s stock, valued at $1,669,360.65. This represents a 5.53% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Todd P. Kelsey sold 1,000 shares of the stock in a transaction that occurred on Wednesday, May 6th. The shares were sold at an average price of $270.75, for a total transaction of $270,750.00. Following the sale, the chief executive officer directly owned 73,888 shares of the company’s stock, valued at approximately $20,005,176. This represents a 1.34% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last 90 days, insiders sold 18,471 shares of company stock valued at $4,719,291. 1.78% of the stock is currently owned by insiders.

Institutional Investors Weigh In On Plexus

A number of large investors have recently made changes to their positions in PLXS. Covestor Ltd raised its holdings in shares of Plexus by 207.7% during the fourth quarter. Covestor Ltd now owns 240 shares of the technology company’s stock valued at $35,000 after acquiring an additional 162 shares during the period. Allworth Financial LP raised its holdings in shares of Plexus by 70.1% during the third quarter. Allworth Financial LP now owns 250 shares of the technology company’s stock valued at $36,000 after acquiring an additional 103 shares during the period. Johnson Financial Group Inc. acquired a new stake in shares of Plexus during the third quarter valued at approximately $72,000. Farther Finance Advisors LLC raised its holdings in shares of Plexus by 114.7% during the fourth quarter. Farther Finance Advisors LLC now owns 511 shares of the technology company’s stock valued at $75,000 after acquiring an additional 273 shares during the period. Finally, EverSource Wealth Advisors LLC raised its holdings in shares of Plexus by 583.3% during the second quarter. EverSource Wealth Advisors LLC now owns 574 shares of the technology company’s stock valued at $78,000 after acquiring an additional 490 shares during the period. Institutional investors and hedge funds own 94.45% of the company’s stock.

About Plexus

Plexus Corp. (NASDAQ: PLXS) is a global provider of electronics manufacturing services (EMS) and precision engineered electronics solutions. Headquartered in Neenah, Wisconsin, the company partners with original equipment manufacturers across industries such as medical, industrial, aerospace and defense, computing, and communications. Plexus offers a full suite of services that span new product introduction, product lifecycle management, supply chain management, printed circuit board assembly, system integration, and aftermarket support.

Founded in 1979, Plexus has grown from a regional electronics assembler into a multinational organization with manufacturing and engineering centers across North America, Europe, and Asia.